MedTrace Logo

Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in CAPD Patients

NCT01785641 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-02-21

No results posted yet for this study

Summary

To compare the efficacy of single versus combined antibiotic therapy for bacterial peritonitis in CAPD patients.

Conditions

  • Peritonitis

Interventions

DRUG

ceftazidime+ciprofloxacin

2 synergistic antibiotics: ceftazidime IP + ciprofloxacin po for gram negative bacterial peritonitis

DRUG

ceftazidime monotherapy

ceftazidime IP for gram negative bacterial peritonitis

DRUG

cefazolin+gentamicin

cefazolin IP + gentamicin IP for gram positive bacterial peritonitis

DRUG

cefazolin monotherapy

cefazolin IP for gram positive bacterial peritonitis

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Nalinee Saiprasertkit, MD. · Chulalongkorn University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01785641 on ClinicalTrials.gov